← back to search

Eric Nuermberger

Johns Hopkins University · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Tuberculosis Research and Epidemiology, Pneumonia and Respiratory Infections, Mycobacterium research and diagnosis, and Antibiotics Pharmacokinetics and Efficacy.
h-index
22
citations
2,697
works
32
NIH funding
primary concept
email

Recent publications

Risk-stratified treatment for drug-susceptible pulmonary tuberculosis
Nature Communications 2024cited by 26position: middledoi
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis
The Lancet Respiratory Medicine 2019cited by 118position: middledoi
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
The Lancet Respiratory Medicine 2017cited by 673position: middledoi
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial
American Journal of Respiratory and Critical Care Medicine 2014cited by 112position: middledoi
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
The Journal of Infectious Diseases 2012cited by 110position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Susan E. Dorman · Medical University of South Carolina2 papers (2012–2014)Payam Nahid · Global Brain Health Institute2 papers (2012–2014)Grace Muzanyi · University Hospitals of Cleveland2 papers (2012–2014)Marc Weiner · Hôpital Beau-Séjour2 papers (2012–2014)Stefan Goldberg · Centers for Disease Control and Prevention2 papers (2012–2014)Jason E. Stout · Duke University2 papers (2012–2014)Neil W. Schluger · Westchester Medical Center2 papers (2012–2014)John L. Johnson · CTS Corporation (United States)2 papers (2012–2014) · 2 papers (2012–2014)Andrew Vernon · Centers for Disease Control and Prevention2 papers (2012–2014) · 2 papers (2012–2014)Charles M. Heilig · Centers for Disease Control and Prevention2 papers (2012–2014) · 1 papers (2014–2014) · 1 papers (2012–2012)Radojka M. Savić · Global Brain Health Institute1 papers (2014–2014)Kelly E. Dooley · MUJHU Research Collaboration1 papers (2014–2014)Masahiro Narita · Public Health – Seattle & King County1 papers (2012–2012) · 1 papers (2012–2012) · 1 papers (2014–2014)Susan M. Ray · Emory University1 papers (2012–2012)